Filing Flows › Scribe Therapeutics (SCTX) › How it makes money
How Scribe Therapeutics (SCTX) makes money
Scribe Therapeutics (SCTX) made $1.9M of revenue in the second quarter 2026 (Q2 2026), -61% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $1.9M | 100.0% |
| Income tax | $212K | 11.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $1.9M | -61% |
From Scribe Therapeutics' 10-Q filed Sep 2, 2026 (on EDGAR).
Questions
How does Scribe Therapeutics make money?
Scribe Therapeutics (SCTX) made $1.9M of revenue in the second quarter 2026 (Q2 2026), -61% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.